Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular smooth muscle ATP-sensitive potassium (K_ATP) channel is a hetero-octameric protein complex typically composed of four inwardly rectifying potassium channel subunits (Kir6.1) and four regulatory sulfonylurea receptor subunits (SUR2B) (Source: UniProt P48048, O60706). These channels serve as critical metabolic sensors, coupling the intracellular ATP/ADP ratio to the membrane potential of vascular smooth muscle cells (Source: PubMed PMID: 22523311). Under conditions of metabolic stress or pharmacological activation, the opening of these channels leads to potassium efflux and membrane hyperpolarization. This hyperpolarization prevents the activation of voltage-gated calcium channels, thereby reducing calcium entry and promoting vasodilation and decreased vascular resistance (Source: StatPearls, "Potassium Channel Openers"). Clinically, these channels are targets for vasodilators such as minoxidil and diazoxide, which are used in the management of refractory hypertension and hypertensive emergencies (Source: PubChem). Mutations in the genes encoding the K_ATP subunits, KCNJ8 and ABCC9, are associated with Cantu syndrome, a multi-system disorder characterized by hypertrichosis, distinctive facial features, and cardiovascular defects like cardiomegaly (Source: NIH, Genetic and Rare Diseases Information Center). Conversely, non-selective sulfonylureas used in diabetes treatment, such as glibenclamide, can inhibit these channels, which may influence vascular responses during ischemia (Source: PubMed PMID: 10405233).
Potassium channel openers bind to the regulatory SUR2B subunit, promoting the open state of the Kir6.1 pore. This leads to potassium efflux and membrane hyperpolarization, which closes voltage-gated calcium channels, decreases intracellular calcium, and induces vascular smooth muscle relaxation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle ATP-sensitive potassium channel (VSM K_ATP channel).